Although further clinical research is required to evaluate the suitability for clinical application of the marker for RNase1 described herein, it is likely that it will contribute to the diagnosis and cure of patients with PaCa. Here, RNASE1 is linked to permanent neonatal diabetes mellitus-pancreatic and cerebellar agenesis syndrome.